Search research articles
Contact Us
Filters
Showing results (241-250 of 627) with videos related to
Page
of 63
Sort By:
European Heart Journal
|
April 5, 2007
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial
Chadwick D Miller, Anindita Banerjee, Kenneth W Mahaffey, et al.
European Heart Journal
|
September 12, 2018
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
Gregg W Stone, Philippe Généreux, Robert A Harrington, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 31, 2023
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial
Sjoukje van der Hoek, Niels Jongs, Megumi Oshima, et al.
International Journal of Cardiology
|
October 15, 2017
Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trials
Alon Eisen, Robert A Harrington, Gregg W Stone, et al.
Circulation
|
June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial
Kenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
International Journal of Cardiology
|
June 23, 2020
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program
Clare Arnott, Brendon L Neuen, Hiddo J L Heerspink, et al.
Journal of Medical Internet Research
|
December 20, 2024
Resting Heart Rate and Associations With Clinical Measures From the Project Baseline Health Study: Observational Study
Kent Y Feng, Sarah A Short, Sohrab Saeb, et al.
European Heart Journal
|
April 14, 2006
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study
Abhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, et al.
The Lancet. Diabetes & Endocrinology
|
October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
Megumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Circulation. Cardiovascular Interventions
|
October 5, 2019
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial
Aman Kansal, Zhen Huang, Frank W Rockhold, et al.
Page
of 63
Search research articles
Search
Showing results (241-250 of 627) with videos related to
Sort By:
Page
of 63
European Heart Journal
|
April 5, 2007
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial
Chadwick D Miller, Anindita Banerjee, Kenneth W Mahaffey, et al.
European Heart Journal
|
September 12, 2018
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
Gregg W Stone, Philippe Généreux, Robert A Harrington, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 31, 2023
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial
Sjoukje van der Hoek, Niels Jongs, Megumi Oshima, et al.
International Journal of Cardiology
|
October 15, 2017
Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trials
Alon Eisen, Robert A Harrington, Gregg W Stone, et al.
Circulation
|
June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial
Kenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
International Journal of Cardiology
|
June 23, 2020
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program
Clare Arnott, Brendon L Neuen, Hiddo J L Heerspink, et al.
Journal of Medical Internet Research
|
December 20, 2024
Resting Heart Rate and Associations With Clinical Measures From the Project Baseline Health Study: Observational Study
Kent Y Feng, Sarah A Short, Sohrab Saeb, et al.
European Heart Journal
|
April 14, 2006
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study
Abhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, et al.
The Lancet. Diabetes & Endocrinology
|
October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
Megumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Circulation. Cardiovascular Interventions
|
October 5, 2019
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial
Aman Kansal, Zhen Huang, Frank W Rockhold, et al.
Page
of 63